Search Results - "Schwarze, J K"
-
1
Metabolic regulation by prostaglandin E2 impairs lung group 2 innate lymphoid cell responses
Published in Allergy (Copenhagen) (01-03-2023)“…Background Group 2 innate lymphoid cells (ILC2s) play a critical role in asthma pathogenesis. Non‐steroidal anti‐inflammatory drug (NSAID)‐exacerbated…”
Get full text
Journal Article -
2
Prostaglandin E2 promotes intestinal inflammation via inhibiting microbiota-dependent regulatory T cells
Published in Science advances (12-02-2021)“…The gut microbiota fundamentally regulates intestinal homeostasis and disease partially through mechanisms that involve modulation of regulatory T cells…”
Get full text
Journal Article -
3
Metabolic regulation by prostaglandin E 2 impairs lung group 2 innate lymphoid cell responses
Published in Allergy (Copenhagen) (01-03-2023)“…Group 2 innate lymphoid cells (ILC2s) play a critical role in asthma pathogenesis. Non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease…”
Get full text
Journal Article -
4
Prostaglandin E 2 promotes intestinal inflammation via inhibiting microbiota-dependent regulatory T cells
Published in Science advances (12-02-2021)“…The gut microbiota fundamentally regulates intestinal homeostasis and disease partially through mechanisms that involve modulation of regulatory T cells (T ),…”
Get full text
Journal Article -
5
42PA phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and avelumab (AVE) plus intravenous low-dose nivolumab (NIVO) in patients with advanced solid tumors
Published in Annals of oncology (01-12-2018)Get full text
Journal Article -
6
P06.05.A Repeated intracranial administration of ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial
Published in Neuro-oncology (Charlottesville, Va.) (05-09-2022)“…Abstract Background Perioperative intracerebral (iCE) administration of ipilimumab (IPI) and nivolumab (NIVO) in combination with IV NIVO was shown to be…”
Get full text
Journal Article -
7
21PBaseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab
Published in Annals of oncology (01-12-2018)Get full text
Journal Article -
8
-
9